ArticleTherapeutic advances in neurological disorders2024

Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysis.

Guillemette de la Borderie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.